Vox Sanguinis | 2021
Impact of pathogen reduction methods on immunological properties of the COVID‐19 convalescent plasma
Abstract
COVID‐19 convalescent plasma is an experimental treatment against SARS‐CoV‐2. The aim of this study is to assess the impact of different pathogen reduction methods on the levels and virus neutralizing activity of the specific antibodies against SARS‐CoV2 in convalescent plasma.